StockData
Entera Bio Ltd. logo

Entera Bio Ltd. (ENTX) income statement

ENTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$3.26+0.26 (+8.67%)

Close on Nov 18, 2026Market cap $564.44MP/E –Yield –

Entera Bio Ltd. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2025
-108.0%

Financial strength

Current ratio
8.98
Debt to equity
–
Debt to assets
–
Cash to current liabilities
537.5%

Valuation

P/E ratio
–
Price to sales
–
Price to book
77.68
Dividend yield
–

See a number that looks wrong?